Cargando…

Neutron crystallography aids in drug design

Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal et al. (2016), IUCrJ, 3, 319–325] who describe t...

Descripción completa

Detalles Bibliográficos
Autor principal: Blakeley, M. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391850/
https://www.ncbi.nlm.nih.gov/pubmed/28461889
http://dx.doi.org/10.1107/S2052252516013439
_version_ 1783229345600372736
author Blakeley, M. P.
author_facet Blakeley, M. P.
author_sort Blakeley, M. P.
collection PubMed
description Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal et al. (2016), IUCrJ, 3, 319–325] who describe the room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor methazolamide to 2.2 Å resolution, and compare this with the previously determined room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor acetazolamide to 2.0 Å resolution [Fisher et al. (2012). J. Am. Chem. Soc.134, 14726–14729].
format Online
Article
Text
id pubmed-5391850
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-53918502017-05-01 Neutron crystallography aids in drug design Blakeley, M. P. IUCrJ Scientific Commentaries Since drugs bind to their targets through directional H bonding and non-directional hydrophobic and electrostatic interactions, neutron crystallography can help guide structure-based drug design. This is illustrated by McKenna and co-workers [Aggarwal et al. (2016), IUCrJ, 3, 319–325] who describe the room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor methazolamide to 2.2 Å resolution, and compare this with the previously determined room-temperature neutron structure of human carbonic anyhydrase II in complex with the clinical inhibitor acetazolamide to 2.0 Å resolution [Fisher et al. (2012). J. Am. Chem. Soc.134, 14726–14729]. International Union of Crystallography 2016-08-31 /pmc/articles/PMC5391850/ /pubmed/28461889 http://dx.doi.org/10.1107/S2052252516013439 Text en © M. P. Blakeley 2016 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Scientific Commentaries
Blakeley, M. P.
Neutron crystallography aids in drug design
title Neutron crystallography aids in drug design
title_full Neutron crystallography aids in drug design
title_fullStr Neutron crystallography aids in drug design
title_full_unstemmed Neutron crystallography aids in drug design
title_short Neutron crystallography aids in drug design
title_sort neutron crystallography aids in drug design
topic Scientific Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391850/
https://www.ncbi.nlm.nih.gov/pubmed/28461889
http://dx.doi.org/10.1107/S2052252516013439
work_keys_str_mv AT blakeleymp neutroncrystallographyaidsindrugdesign